⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SUPN News
Supernus Pharmaceuticals, Inc.
Form 8-K
sec.gov
SUPN
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
globenewswire.com
SUPN
Parkinson's Disease Clinical Trial Pipeline Boom as 150+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
ANVS
SUPN
ABBV
VNDA
JAZZ
ACAD
MRK
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
globenewswire.com
SUPN
Newron Provides Update Following Type A Meeting With the FDA
businesswire.com
SUPN
Form 8-K
sec.gov
SUPN
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
globenewswire.com
SUPN
Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight
prnewswire.com
AEON
ABBV
SUPN
Supernus Pharmaceuticals to Participate in June Investor Conferences
globenewswire.com
SUPN
Form 8-K
sec.gov
SUPN